Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0917798 (
cerebral ischemia
)
17,036
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Using mRNA differential display to identify
cerebral ischemia
-responsive mRNAs, we isolated and cloned a cDNA derived from a novel gene, that has been designated
LCHN
. Antisense mRNA in situ hybridization and immunoblotting confirmed
LCHN
expression to be induced in the rat hippocampus following transient forebrain ischemia. The deduced amino acid sequence of the novel
LCHN
cDNA contains an open reading frame of 455 amino acids, encoding a protein with a predicted molecular mass of approximately 51 kDa. Although
LCHN
is highly conserved between rat, mouse, and human, the deduced amino acid sequence of
LCHN
does not possess significant homology to other known genes.
LCHN
immunoreactivity is detected within the somatodendritic compartment of neurons, is also present on dendritic growth cones, but is not detected on astrocytes. The induction of
LCHN
in the hippocampus following ischemic injury may have functional consequences, as the ectopic over-expression of
LCHN
generated neurons with longer and more branched axons and dendrites. Taken together, these data suggest that
LCHN
could play a role in neuritogenesis, as well as in neuronal recovery and/or restructuring in the hippocampus following transient
cerebral ischemia
.
...
PMID:Isolation and characterization of LCHN: a novel factor induced by transient global ischemia in the adult rat hippocampus. 1739 67